On the latest episode of Leaders in Pharma, I'm joined by Dr. Jonathan Loughrey, associate director of physical sciences and isotope chemistry and Terry Ernest, director of manufacturing science and technology at Almac Group, where we will discuss an overview of Almac technologies to support, development and final delivery of client targets with enhanced solubility properties.
All content for The MedTalk Podcast is the property of The MedTalk Podcast and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On the latest episode of Leaders in Pharma, I'm joined by Dr. Jonathan Loughrey, associate director of physical sciences and isotope chemistry and Terry Ernest, director of manufacturing science and technology at Almac Group, where we will discuss an overview of Almac technologies to support, development and final delivery of client targets with enhanced solubility properties.
In this episode we're bringing you something a little different. Earlier this year, one of our sister publications, European Pharmaceutical Manufacturer, secured a remarkable interview with Thermo Fisher Scientific's President of EMEA, Urmi Prasad Richardson.
In this insightful discussion, we delve into what it takes to be a leader in the pharmaceutical industry.
The MedTalk Podcast
On the latest episode of Leaders in Pharma, I'm joined by Dr. Jonathan Loughrey, associate director of physical sciences and isotope chemistry and Terry Ernest, director of manufacturing science and technology at Almac Group, where we will discuss an overview of Almac technologies to support, development and final delivery of client targets with enhanced solubility properties.
